CONVERGENCE PHARMACEUTICALS LIMITED
ActiveCompany number 09376285
Maidenhead, England · Incorporated 6 January 2015
Building 5 Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UD, England
Last updated on 9 September 2026
Research and experimental development on biotechnology · SIC 72110
Company history
SILVER NEWCO CO LIMITED · 6 January 2015 – 24 April 2015
Company overview
Convergence Pharmaceuticals Limited is an active private limited company incorporated on 6 January 2015 and registered in England and Wales. It is wholly owned and controlled by Biogen Inc., which holds 75–100% of the shares and voting rights and the right to appoint and remove directors. The company’s registered office is at Building 5, Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UD.
The company’s principal activity is research and experimental development in the pharmaceutical sector (SIC 72110). It files small company accounts; the most recent accounts, made up to 31 December 2024, are due for filing by 30 September 2026. The latest confirmation statement was filed on 17 January 2026 with no updates.
Current directors are Helen Elizabeth Hanby (appointed 2020), Kylie Michele Bromley (appointed 2022), and Amit Singh Purwaha (appointed 14 July 2025). A director was terminated on 23 July 2025. The company has no charges, no insolvency history and has never been liquidated.
Compliance
Financial snapshot
Detailed figures (assets, liabilities, net worth) are available in the full credit report.
Officers
No officers on record.
Persons with significant control
Funding
3 funding roundsFiling history
No filings match this type.
Risk at a glance
- Company active
- Accounts up to date
- Confirmation statement up to date
- No insolvency history
- No registered charges
- Credit score
- Recommended limit
- Payment risk
Get the complete credit report
- Detailed financial statements
- Credit score & payment risk
- CCJs, charges & insolvency checks
- Recommended credit limit
Secure checkout · Report delivered instantly